RCS - Releaf Dispensary Ld - Releaf Acquires Domain Releaf.com for £110,000

TrustpilotAnnouncement

Today 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250902:nRSB7062Xa&default-theme=true

RNS Number : 7062X  Releaf Dispensary Ltd  02 September 2025

Releaf Acquires Domain Releaf.com for £110,000 to Support Long Term Growth.

 

Releaf Acquires Domain Releaf.com for £110,000.

The UK's fastest-growing medicinal cannabis clinic begins international
strategy with further online investment.

LONDON, September 2, 2025. Releaf (https://releaf.co.uk) , the UK's
fastest-growing medicinal cannabis clinic, has acquired the domain Releaf.com
(https://releaf.com) for £110,000 as part of its global expansion strategy.
The move comes as the company overtakes £2.1 million in monthly revenue and
prepares to take its proven healthcare model to international markets.

Releaf's technology platform, fully integrated with the NHS Spine, now serves
over 300,000 unique website visitors monthly. The platform uses AI-assisted
triage to match patients with specialist prescribers and delivers doctor-led
care directly to patients' doors, effectively removing traditional barriers to
access.

Jon Dunn, Marketing Director at Releaf, explains, "Releaf.com
(http://releaf.com) is our launchpad for global growth. This isn't just a
domain, it's our passport to every market we enter. It gives us instant
credibility, makes our brand unforgettable, and ensures patients worldwide
know exactly where to find us."

The company has achieved significant growth in the UK market, onboarding over
120 new patients daily and conducting more than 300 consultations each day.
This momentum is driving substantial expansion, with plans to double clinical
operations month-on-month to reach over 6,000 initial consultation slots per
month by year end.

Having demonstrated its approach works in the UK's highly regulated healthcare
environment, Releaf is now positioning its technology-led model for
international rollout. The company is targeting markets where patients face
similar structural challenges in accessing cannabinoid healthcare.

Releaf continues to reinvest into clinician onboarding, patient support, and
platform enhancements, ensuring high standards of care while building capacity
for international expansion. With European operations already underway, the
company is well-positioned to become a leading provider of regulated
cannabinoid healthcare globally.

About Releaf

Launched in 2024, Releaf (https://releaf.co.uk) Dispensary Ltd the UK's
fastest-growing and most-trusted* medical cannabis clinic, serving patients
through its advanced healthtech platform. With a prescriber network of over 40
specialists, we deliver evidence-based cannabinoid care directly to patients'
homes through tailored treatment plans.Fully integrated with NHS systems,
Releaf has transformed access to medicinal cannabis treatment in the UK and is
now expanding internationally. *According to Trustpilot.

Media Contact:  Sophie Stephen, Marketing Manager,
sophie.stephen@releaf.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABSGDCGUGDGUD